Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease

BACKGROUND: Clinicians often utilize off-label dose escalation of ustekinumab (UST) in Crohn’s disease (CD) patients with disease refractory to standard dosing. Previous studies report mixed results with dose escalation of UST. METHODS: A retrospective observational study of 143 adult patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Therap Adv Gastroenterol
Main Authors: Haider, Syedreza A., Yadav, Abhijeet, Perry, Courtney, Su, Leon, Akanbi, Olalekan, Kudaravalli, Praneeth, Tripathi, Nishant, Hashim, Mahmoud A., Abdelsalam, Mohammed, Hussein, Mohamed, Elkheshen, Ahmed, Patel, Vihang, Ali, Saad Emhmed, Lamb, Latoya, Ingram, Karen, Mayne, Casie, Stuffelbeam, Amy B., Flomenhoft, Deborah, Stromberg, Arnold, Barrett, Terrence A.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7576911/
https://ncbi.nlm.nih.gov/pubmed/33133239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284820959245
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados